An FDA Advisory Committee was swayed by the “preponderance of the evidence” to support a drug to treat the ultra-rare Barth syndrome home.agencyiq.com/article/000001…

Please get your story straight, Metrorail Info. I get on at Medical Center after taking the shuttle from Grosvenor. The train pulls in. We all start to board but the driver says “out of service” and the doors close. Then the doors reopen and people board this same train. Metro Forward

SUPER BOWL CHAMPIONS! THIS ONE’S FOR YOU PHILLY!

ITS 3:30AM THE EAGLES ARE THE SUPER CHAMPIONS!!!

Digital Health and AI session starts now in Georgetown #CRT2025. It’s great to be back!

At the MedTech Town Hall at #CRT2025. Buzz word of the session so far concerning the regulatory landscape in 2025: “uncertainty”

Hello Metrorail Info Metro Forward are you running late trains because of the late Nats game? I know closing time is 1 am, want to make sure I can get home. Thanks!

I can relate to this!

Hi Metro Forward Metrorail Info. Why are so many fare gates closed at the Shady Grove Metro Station? 2 of the 3 on the platform and half of the ones on the lower level are closed, forcing rush hour commuters to squeeze into the remaining open ones.

It appears this is why. Makes sense. Hope they resolve this situation safely for everyone involved.

Good morning, Pepco. The power in our community fluctuated several times on Thursday, and it just happened again a few minutes ago, where it goes out and quickly comes back. Can you please explain what is happening and why?

We’re heartbroken to share the passing of our dear friend and legendary voice, Pierre Robert. You will be missed beyond words.

Woah. FDA's top drug regulator, George Tidmarsh, apparently placed on administrative leave. Apparently over major concerns about FDA's priority voucher program, as well as his posting about surrogate endpoints on LinkedIn. nytimes.com/2025/11/02/hea…

I believe AgencyIQ was responsible for first noting and surfacing Tidmarsh's LinkedIn posts, which I posted about here: x.com/AlecGaffney/st…

STAT reports that Tidmarsh actually resigned following being placed on administrative leave. statnews.com/2025/11/02/fda…

A scoop from today's edition of my FDA Today newsletter: CBER has named a new #2 in its cell and gene therapy division, the Office of Therapeutic Products. MEGHA KAUSHAL is serving as the acting deputy director as of last week.

A small scoop from today's edition of my FDA Today newsletter: The top medical policy official at FDA's drug division, M. Khair ElZarrad, is stepping down later this month. Another tough loss for an already battered CDER.